Virax chairman Wayne Millen.

Virax takeover clinches anti-cancer drug

Virax Holdings has agreed to acquire Pathway Oncology in a takeover under which the Australia-listed company will gain control of a global licence for emerging anti-cancer technology.


(existing subscribers)

The password field is case sensitive.
Request new password

Add your comment

BNIQ sponsored byECU School of Business and Law


6th-Australian Institute of Management WA20,000
7th-Murdoch University15,536
8th-South Regional TAFE10,549
9th-Central Regional TAFE9,064
10th↑The University of Notre Dame Australia6,720
49 tertiary education & training providers ranked by total number of students in WA

Number of Employees

BNiQ Disclaimer